Clinical Trial Update: A Study to Evaluate Gemcitabine Plus Cisplatin in the Treatment of TNBC Patients Following Neoadjuvant Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine plus cisplatin in triple negative breast cancer patients after neoadjuvant chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Fudan University | Conditions: Triple Negative Breast Cancer | Phase 2 | Status: UNKNOWN